作者：
Jeremie,Calais [1]
;
Andrei,Gafita [2]
;
Matthias,Eiber [1]
;
Wesley R,Armstrong [1]
;
Jeannine,Gartmann [1]
;
Pan,Thin [1]
;
Kathleen,Nguyen [1]
;
Vincent,Lok [1]
;
Laura,Gosa [3]
;
Tristan,Grogan [4]
;
Rouzbeh,Esfandiari [5]
;
Martin,Allen-Auerbach [5]
;
Andrew,Quon [5]
;
Shadfar,Bahri [1]
;
Pawan,Gupta [1]
;
Linda,Gardner [6]
;
David,Ranganathan [1]
;
Roger,Slavik [7]
;
Magnus,Dahlbom [8]
;
Ken,Herrmann [9]
;
Ebrahim,Delpassand [8]
;
Wolfgang P,Fendler [5]
;
Johannes,Czernin
作者单位：
Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.
[1]
Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.;Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany.
[2]
Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
[3]
Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.
[4]
Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.;Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, California.;Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
[5]
RadioMedix, Inc., Houston, Texas; and.
[6]
Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.;Physics & Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
[7]
Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, California.;Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
[8]
Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.;RadioMedix, Inc., Houston, Texas; and.
[9]
DOI
10.2967/jnumed.121.261982
PMID
34016732
发布时间
2024-09-13
换一批
换一批
